Eli Lilly and (LLY) Business Metrics | Revenue Breakdown & Segment Analysis - Stocknear

Eli Lilly and

NYSE: LLY · Real-Time Price · USD
752.35
13.71 (1.86%)
At close: Sep 09, 2025, 12:17 PM

Immunology Revenue

History

Quarter Value Change Growth
Jun 30, 2025 1.26B 167.6M +15.40%
Mar 31, 2025 1.09B -97.7M -8.24%
Sep 30, 2024 1.19B 103.3M +9.54%
Jun 30, 2024 1.08B 529.9M +95.91%
Mar 31, 2024 552.5M -1.22B -68.75%
Sep 30, 2023 1.77B 1.38B +356.64%
Jun 30, 2023 387.2M 26.7M +7.41%
Mar 31, 2023 360.5M -73.3M -16.90%
Sep 30, 2022 433.8M -25.7M -5.59%
Jun 30, 2022 459.5M -12.4M -2.63%
Mar 31, 2022 471.9M -54.8M -10.40%
Sep 30, 2021 526.7M -70.4M -11.79%
Jun 30, 2021 597.1M 58.2M +10.80%
Mar 31, 2021 538.9M 68.2M +14.49%
Sep 30, 2020 470.7M 48.2M +11.41%
Jun 30, 2020 422.5M -41M -8.85%
Mar 31, 2020 463.5M 36.8M +8.62%
Sep 30, 2019 426.7M -26M -5.74%
Jun 30, 2019 452.7M 59.6M +15.16%
Mar 31, 2019 393.1M -328.6M -45.53%
Dec 31, 2015 721.7M -2.8M -0.39%
Sep 30, 2015 724.5M -39.4M -5.16%
Jun 30, 2015 763.9M 38.6M +5.32%
Mar 31, 2015 725.3M -143.2M -16.49%
Dec 31, 2014 868.5M -13.9M -1.58%
Sep 30, 2014 882.4M 24M +2.80%
Jun 30, 2014 858.4M 94.1M +12.31%
Mar 31, 2014 764.3M -110.1M -12.59%
Dec 31, 2013 874.4M 52.6M +6.40%
Sep 30, 2013 821.8M 13.7M +1.70%
Jun 30, 2013 808.1M 43.9M +5.74%
Mar 31, 2013 764.2M -75M -8.94%
Dec 31, 2012 839.2M 47.5M +6.00%
Sep 30, 2012 791.7M -55.1M -6.51%
Jun 30, 2012 846.8M 42.9M +5.34%
Mar 31, 2012 803.9M -13.9M -1.70%
Sep 30, 2011 817.8M -8M -0.97%
Jun 30, 2011 825.8M -14.1M -1.68%
Mar 31, 2011 839.9M -140.4M -14.32%
Sep 30, 2010 980.3M n/a n/a